Pharmaceutical compositions useful as cellular immunopotentiator

Details Pharmaceutical compositions useful as cellular immunopotentiator Pharmaceutical compositions useful as cellular immunopotentiator

1980-04-04

1982-02-16

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Lymphokine

435235, 435237, A61K 39285

Patent

active

043159141

ABSTRACT:
Compositions comprising an attenuated strain of vaccinia virus as active ingredient are found to be useful as cellular immunopotentiator and antitumor agent. The attenuated strain of vaccinia virus is obtained by serial passages of vaccinia virus in cell monolayers of chick embryo cells, preferably after the serial passages in mouse kidney cell monolayers.

REFERENCES:
patent: 2078041 (1937-04-01), Terry
patent: 2112507 (1938-03-01), Sukegawa
patent: 2787577 (1957-04-01), Allisbaugh
patent: 2879202 (1959-03-01), Aiston et al.
patent: 3135661 (1964-06-01), Bartell et al.
patent: 3429965 (1969-02-01), Selencze et al.
patent: 3985615 (1976-10-01), Kubo
patent: 4000256 (1976-12-01), Hilleman et al.
patent: 4008317 (1977-02-01), Gits
patent: 4053582 (1977-10-01), Stickl
patent: 4191745 (1980-03-01), Mayr et al.
Buxton Animal Microbiology, vol. 2 (1977), Blackwell Sci. Pub., p. 409, 414, 420-421, 464-474, 676-710.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions useful as cellular immunopotentiator does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions useful as cellular immunopotentiator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions useful as cellular immunopotentiator will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-942621